Pfenex Launches Reagent Proteins Business

Xconomy San Diego — 

San Diego’s Pfenex said today it has launched a new business division called Reagent Proteins, which is targeting research biomedical laboratories that need complex reagent grade proteins. The new business will initially offer a product list with more than 2,300 proteins, including stem cell growth factors, cytokines, chemokines, and enzymes. Pfenex, which was spun out from Dow Chemical late last year, has developed what it calls the Pfenex Expression Technology platform, which is based on the microbe Pseudomonas fluorescens, to produce research proteins, reagent proteins, biosimilars, and other biopharmaceuticals.